Styrene

Styrene

SCHEMBL697500

C=Cc1ccc(S(=O)(=O)O)cc1.C=Cc1ccccc1.[NaH]

nearest known ligand 0.81

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.81
TSHR P16473 3/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
ALDH1A1 P00352 3/20 0.54
CYP2D6 P10635 2/20 0.48
POLB P06746 1/20 0.48
LMNA P02545 1/20 0.43
NT5E P21589 1/20 0.42
MCL1 Q07820 1/20 0.41
DUSP22 Q9NRW4 1/20 0.40
PTGS2 P35354 4/20 0.39
SNCA P37840 1/20 0.38
PTPN2 P17706 1/20 0.36
PTPN1 P18031 1/20 0.36
PTPN5 P54829 1/20 0.36
AKR1C2 P52895 1/20 0.36
AKR1C1 Q04828 1/20 0.36
AKR1C3 P42330 1/20 0.36
MAPK1 P28482 1/20 0.36
PTGS1 P23219 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Styrene SCHEMBL27867074 0.98 TDP1 (0.84) TDP1TSHRSMN1; SMN2ALDH1A1CYP2D6
Styrene SCHEMBL7857368 0.92 TDP1 (0.73) TDP1TSHRSMN1; SMN2ALDH1A1CYP2D6
SCHEMBL6035162 0.92 TDP1 (0.95) TDP1TSHRSMN1; SMN2ALDH1A1CYP2D6
SCHEMBL94888 0.92 TDP1 (0.95) TDP1TSHRSMN1; SMN2ALDH1A1CYP2D6
Biphenyl SCHEMBL31074210 0.91 TDP1 (0.78) TDP1TSHRSMN1; SMN2ALDH1A1CYP2D6
Styrene SCHEMBL27847794 0.90 TDP1 (0.70) TDP1TSHRSMN1; SMN2ALDH1A1CYP2D6
Styrene SCHEMBL27791421 0.90 TDP1 (0.70) TDP1TSHRSMN1; SMN2ALDH1A1CYP2D6
Water SCHEMBL2898588 0.90 TDP1 (0.91) TDP1TSHRSMN1; SMN2ALDH1A1CYP2D6
SCHEMBL28272951 0.90 TDP1 (0.91) TDP1TSHRSMN1; SMN2ALDH1A1CYP2D6
SCHEMBL31126649 0.90 TDP1 (1.00) TDP1TSHRSMN1; SMN2ALDH1A1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10023675-B2 Polymer nanoparticles ETH ZUERICH (CH) 2018-07-17 US disclosed
US-20160024241-A1 POLYMER NANOPARTICLES ETH ZUERICH (CH) 2016-01-28 US disclosed
US-9181358-B2 Polymer nanoparticles ETH ZUERICH (CH) 2015-11-10 US disclosed
EP-2421903-B1 POLYMER NANOPARTICLES ETH ZUERICH (CH) 2014-11-19 EP disclosed
WO-2014127179-A1 MODIFIED HYDROPHOBIC SPONGES THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2014-08-21 WO disclosed
US-20120115963-A1 POLYMER NANOPARTICLES ETH ZUERICH (CH) 2012-05-10 US disclosed
EP-2421903-A1 POLYMER NANOPARTICLES ETH Zurich (CH) 2012-02-29 EP disclosed
WO-2010121387-A1 POLYMER NANOPARTICLES ETH Zürich (CH) 2010-10-28 WO disclosed
US-6559255-B2 Using nitrone compound as controller SYMYX TECHNOLOGIES INC. 2003-05-06 US disclosed
US-20020013430-A1 Controlled free radical emulsion and water-based polymerizations and seeded methodologies FREESLATE, INC. 2002-01-31 US disclosed
EP-1165625-A1 CONTROLLED FREE RADICAL EMULSION AND WATER-BASED POLYMERIZATIONS AND SEEDED METHODOLOGIES Symyx Technologies, Inc. (US) 2002-01-02 EP disclosed
WO-2000053640-A1 CONTROLLED FREE RADICAL EMULSION AND WATER-BASED POLYMERIZATIONS AND SEEDED METHODOLOGIES SYMYX TECHNOLOGIES, INC. (US) 2000-09-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160024241-A1 POLYMER NANOPARTICLES POLQ, POLN, POLA1 TDP1 1337/4885TSHR 4311/4885SMN1; SMN2 1318/4885
US-10023675-B2 Polymer nanoparticles POLQ, POLN, POLA1 TDP1 1337/4885TSHR 4311/4885SMN1; SMN2 1318/4885
US-20120115963-A1 POLYMER NANOPARTICLES POLQ, POLN, POLA1 TDP1 1337/4885TSHR 4311/4885SMN1; SMN2 1318/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.